Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Gains from Investment Securities (2017 - 2019)

enVVeno Medical has reported Gains from Investment Securities over the past 3 years, most recently at $99689.0 for Q4 2019.

  • Quarterly results put Gains from Investment Securities at $99689.0 for Q4 2019, down 10.86% from a year ago — trailing twelve months through Dec 2019 was $99689.0 (down 10.86% YoY), and the annual figure for FY2019 was $99689.0, down 10.86%.
  • Gains from Investment Securities for Q4 2019 was $99689.0 at enVVeno Medical, up from $6137.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NVNO hit a ceiling of $1.4 million in Q4 2017 and a floor of -$14649.0 in Q3 2018.
  • Median Gains from Investment Securities over the past 3 years was $105759.0 (2018), compared with a mean of $297501.0.
  • Peak annual rise in Gains from Investment Securities hit 10.86% in 2019, while the deepest fall reached 96.16% in 2019.
  • enVVeno Medical's Gains from Investment Securities stood at $1.4 million in 2017, then plummeted by 92.14% to $111829.0 in 2018, then fell by 10.86% to $99689.0 in 2019.
  • The last three reported values for Gains from Investment Securities were $99689.0 (Q4 2019), $6137.0 (Q2 2019), and $111829.0 (Q4 2018) per Business Quant data.